NASDAQ$ZJYL
Jin Medical International Lt · Q4 2023 earnings
Q4 2023 earnings · · Investor relations
Briefing
ZJYL Q4 2023 — $700.0M revenue
PRC government could disallow the VIE structure, which would likely result in a material change in our operations and, as a result, the. Jin Medical International Lt reported Q4 2023 results. Net income of $2.9M. Headline numbers extracted from the Form 20-F press release; narrative is light because this row was processed without an LLM call.
- Revenue: $700.0M.
- Net income: $2.9M.
- Operating income: $2.9M.
- Gross profit: $6.8M.
Headline financials
Revenue & EPS history
Jin Medical · Revenue · Quarterly
$19.8M
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 8 quarterly earnings reports · overlaid with Q4 2023
-8.9%
Avg return
Earnings day
-3.1%
Avg return
5 days after
+12.7%
Avg return
30 days after
0%
0 / 8 earnings
Positive
+0.0%
Q3 2026
Best reaction
-19.9%
Q2 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2022 | +0.0% | +10.4% | +6.7% | |
| Q3 2024 | +0.0% | +10.4% | +6.7% | |
| Q3 2026 | +0.0% | +10.4% | +6.7% | |
| Q2 2024 | -7.3% | -11.1% | -2.5% | |
| Q4 2023 | -3.8% | -7.4% | -30.1% | |
| Q2 2022 | -19.9% | -12.4% | +38.1% | |
| Q4 2022 | -19.9% | -12.4% | +38.1% | |
| Q2 2023 | -19.9% | -12.4% | +38.1% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro